Equity Details
Price & Market Data
Price: $41.40
Daily Change: -$4.55 / 10.99%
Daily Range: $40.75 - $48.50
Market Cap: $1,848,126,848
Daily Volume: 525,215
Performance Metrics
1 Week: -0.07%
1 Month: -1.99%
3 Months: 7.69%
6 Months: 17.95%
1 Year: 217.4%
YTD: -0.49%
About Sionna Therapeutics, Inc. (SION)
Explore comprehensive market data for Sionna Therapeutics, Inc. (SION). Currently priced at 41.40, observe its daily movement of -$4.55 / 10.99%. The total market value is 1,848,126,848. Review its performance across various timeframes, including the last week, month, and year, to understand its trajectory.
Company Details
Employees: 59
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; SION-451, which is nucleotide-binding domain 1 stabilizer in Phase 1 trial; and SION-719, which is nucleotide-binding domain 1 stabilizer in Phase 2a proof-of-concept trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.